Published in
Dustri-Verlag, International Journal of Clinical Pharmacology and Therapeutics, 12(43), p. 583-585
DOI: 10.5414/cpp43583
Links
Tools
Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins ? significance for the patient
Journal article published in 2005 by
C. G. Hartinger,
S. Hann 
,
G. Koellensperger ,
M. Sulyok,
M. Groessl,
A. R. Timerbaev,
A. V. Rudnev,
G. Stingeder,
B. K. Keppler
,
G. Koellensperger ,
M. Sulyok,
M. Groessl,
A. R. Timerbaev,
A. V. Rudnev,
G. Stingeder,
B. K. Keppler
This paper is made freely available by the publisher.
Full text: Download
Data provided by 